DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus.

Antoine ParienteVanessa LabatYohann MansiauxFrancesco SalvoBernard BégaudEmanuel RaschiJean-Luc FaillieLouis LétinierJulien Bezin

Published in: Drug safety (2021)

In this study, DPP-4 inhibitor use was not associated with an increased risk of serious muscular injury among patients with type 2 diabetes mellitus using statins or fibrates.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular disease
peritoneal dialysis
resistance training
prognostic factors
cross sectional